How UFP Technologies, Inc. stacks up

UFPT · against 557 other Healthcare companies listed in US-listed

Profitability

83/ 100

Near the top of its peers.

Ranked #85 of 558 · scores higher than 84% of peers

Bars: peers in each 10-point band of the profitability score

38 peers with a profitability score of 80–89, including UFPT · Click a bar to see the companies

Why profitability scores 83?

Weighted metrics compared with all Healthcare companies.

Mainly thanks to its return on assets, return on invested capital and operating margin, which are stronger than most Healthcare peers.

a wider operating margin: stronger than 72% of peers. Operating margin: 15.3% vs peer median 7.1%
a higher return on invested capital: stronger than 76% of peers. Return on invested capital: 13.3% vs peer median 4.7%
a higher return on assets: stronger than 91% of peers. Return on assets: 10.6% vs peer median 1.7%

Metric by metric

Position: dot = UFPT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	UFPT	Peer median	Better than	Weight
Return on invested capitalHigher is better · 517 reported	13.3%	-7.0%	81%	33%
Operating marginHigher is better · 479 reported	15.3%	-2.4%	79%	33%
Return on assetsHigher is better · 582 reported	10.6%	-7.8%	88%	33%
Return on equityHigher is better · 531 reported	17.1%	-19.7%	85%	Context only
Gross marginHigher is better · 601 reported	28.5%	43.9%	42%	Context only

Ranking by profitability score

Top 5 and the companies ranked around UFPT

Rank	Company	Market cap	Profitability	Overall
1	Arbutus Biopharma CorporationABUS · US-listed	595M USD	99	97
1	CorMedix Inc.CRMD · US-listed	433M USD	99	81
1	Exelixis, Inc.EXEL · US-listed	17.9B USD	99	76
1	IDEXX Laboratories, Inc.IDXX · US-listed	52.9B USD	99	57
1	Ironwood Pharmaceuticals, Inc.IRWD · US-listed	578M USD	99	73
⋯
82	Globus Medical, Inc.GMED · US-listed	10.7B USD	84	78
85	Edwards Lifesciences CorporationEW · US-listed	54.9B USD	83	59
85	HealthEquity, Inc.HQY · US-listed	8.4B USD	83	67
85	Protagonist Therapeutics, Inc.PTGX · US-listed	9.1B USD	83	74
85	UFP Technologies, Inc.UFPT · US-listed	2.2B USD	83	61
89	Stryker CorporationSYK · US-listed	119.1B USD	82	57
89	Bio-Techne CorporationTECH · US-listed	11.4B USD	82	64
91	DaVita Inc.DVA · US-listed	11.6B USD	81	57
91	Kiniksa Pharmaceuticals International, plcKNSA · US-listed	7.3B USD	81	74

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…